Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and predictors of hemorrhage in pediatric low-grade glioma.

Journal of neuro-oncology·2026
Same author

FGFR alterations and potential role of FGFR inhibitors in pediatric brain tumors.

Neuro-oncology advances·2026
Same author

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem Gliomas.

JCO precision oncology·2026
Same author

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

Cancer cell·2025
Same author

The Association Between Age and Outcomes of Bevacizumab Treatment in NF2-Related Schwannomatosis.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025

Related Experiment Video

Updated: Mar 20, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K

Pediatric Brain Tumors: An Update.

Devorah Segal1, Matthias A Karajannis2

  • 1Division of Pediatric Hematology/Oncology, Department of Pediatrics, New York, NY.

Current Problems in Pediatric and Adolescent Health Care
|May 28, 2016
PubMed
Summary

Pediatric brain tumors are the most common childhood solid tumors. Recent molecular and genetic research improves diagnosis, risk stratification, and targeted therapies, enhancing survival and reducing toxicity for some young patients.

More Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Area of Science:

  • Pediatric oncology
  • Neuro-oncology
  • Cancer genetics

Background:

  • Brain tumors are the most frequent solid tumors in children, causing significant illness and death.
  • Historically, diagnosis and treatment relied on histology and empirical methods.
  • Recent advancements have deepened the understanding of pediatric brain tumor biology.

Purpose of the Study:

  • To provide an overview of common childhood brain tumors.
  • To highlight recent key advances in the field.
  • To discuss ongoing therapeutic challenges.

Main Methods:

  • Review of current literature on pediatric brain tumors.
  • Analysis of recent molecular and genetic research findings.
  • Synthesis of diagnostic and therapeutic advancements.

Main Results:

  • Improved understanding of pediatric brain tumor biology, molecular, and genetic features.
  • Enhanced diagnostic accuracy and risk stratification.
  • Development of novel biomarkers and molecular targeted therapies leading to improved outcomes for some patients.

Conclusions:

  • Advances in molecular and genetic understanding are transforming pediatric brain tumor care.
  • Novel therapies offer improved survival and reduced toxicity for specific patient groups.
  • Despite progress, significant therapeutic challenges remain in treating childhood brain tumors.